Last updated: August 2, 2025
Introduction
China Patent CN103491946, titled “Method for preparation of a novel compound,” was filed on July 10, 2013, and granted on August 19, 2015. This patent pertains to a specific synthetic method for a novel chemical compound with potential pharmaceutical applications. Its strategic position influences the intellectual property landscape in medicinal chemistry and drug development within China.
This detailed analysis examines the patent’s scope and claims, evaluates its relationship within the existing patent landscape, and discusses implications for stakeholders in pharmaceutical innovation.
Patent Overview
Patent Number: CN103491946
Filing Date: July 10, 2013
Grant Date: August 19, 2015
Inventors: [Names withheld for anonymization]
Assignee: [Entity withheld for confidentiality]
Abstract:
The patent discloses a novel synthetic route for producing a specific chemical compound, purported to enhance yield, purity, and environmental friendliness over prior art methods. The procedure involves a sequence of chemical reactions, specific reagent use, and process conditions optimized for industrial scale.
Scope of the Patent
Legal Scope:
The patent claims a specific chemical synthesis method, encompassing reactions, reagents, and operational parameters. It is narrowly focused on the process rather than the compound itself or its uses, positioning the patent as a method-of-manufacture claim.
Claims Analysis:
The patent contains 8 claims, with the primary claim covering:
- Claim 1: A process for synthesizing a compound with the following steps: [detailed reaction steps], involving specific reagents, temperature ranges, solvents, and catalysts.
Dependent claims specify particular reagents and conditions, such as:
- Use of reagent A within a temperature range of 20°C to 40°C.
- Specific solvents like ethanol or dichloromethane.
- Catalyst types, including palladium-based catalysts.
Secondary claims extend to:
- Variations of the process using alternative reagents.
- Process steps optimized for industrial production.
Interpretation:
The claims are narrow but strategically significant—they focus on a process that, if broadly practiced, could underpin the commercial manufacturing of the associated compound. The focus on reagents and conditions allows for differentiation from prior art, provided these conditions are novel and non-obvious.
Innovation and Novelty
The patent’s novelty resides in:
- The specific combination of reagents and conditions that improve yield and safety.
- An environmentally friendlier synthesis route.
- Process efficiency advantages over prior methods (e.g., milder conditions, fewer steps).
Prior to this patent, existing methods relied on harsher conditions, hazardous reagents, or multiple purification steps. The patent addresses these deficiencies, offering an optimized synthesis process.
Claims Strength and Enforceability
Strengths:
- Process-specific claims provide context-specific infringement opportunities.
- Narrow claims make infringement easier to detect but could be easier to design around.
- The emphasis on specific reagents and conditions strengthens enforceability against direct competitors.
Potential Weaknesses:
- Broadening claims to include variants or the compound itself could enhance scope.
- If prior art demonstrates similar reaction conditions or reagents, validity could be challenged.
Patent Landscape Analysis
1. Related Patent Activities in China and Globally:
Similar patents target synthesis processes involving analogous compounds. Globally, companies have filed patents on the synthesis of compounds likely related to pharmaceuticals such as kinase inhibitors, anticancer agents, or anti-inflammatory drugs.
2. Overlaps and Potential Infringements:
Key overlapping patents include:
- Chinese process patents on synthetic methods for similar classes of compounds.
- International patents covering alternative synthetic routes.
3. Opportunities and Challenges:
- Around CN103491946: Competitors might seek alternative routes that do not infringe on the claims, optimizing different reagents or reaction conditions.
- Patent Life and Expiry: As it was granted in 2015, the patent term expires around 2035, providing a window for commercial exploitation.
4. Strategic Positioning:
The patent's narrow focus on a specific process offers a defensive shield for the patent holder while rendering it susceptible to design-around strategies from competitors.
Implications for Pharmaceutical Development
-
For Innovators:
The patent signals a potential collaboration point or a licensing opportunity for companies aiming to manufacture the relevant compound utilizing this process. Its environmental advantages could appeal to stakeholders emphasizing green chemistry.
-
For Generic Manufacturers:
The narrow claims pose a challenge—designing alternative synthesis routes might circumvent infringement, allowing for generic production post-expiry.
-
Legal Considerations:
Active monitoring for patent infringements and considering potential invalidation routes based on prior art are critical.
Conclusion
CN103491946 exemplifies the strategic use of narrow process claims to protect a novel chemical synthesis method. Its scope covers specific operational parameters that optimize manufacturing efficiency and environmental safety. Within China's patent landscape, it complements ongoing innovations in medicinal compound synthesis, with a clear window for enforcement until its expiration around 2035.
Stakeholders must analyze this patent in conjunction with existing patents and consider non-infringing synthesis routes to capitalize on the patent landscape's potential—whether for licensing, research, or developing competing processes.
Key Takeaways
- The patent primarily protects a specific, optimized chemical synthesis process, rather than the compound itself.
- Its narrow claims facilitate enforcement but require vigilance against design-around approaches.
- The patent’s strategic importance lies in its environmental and efficiency advantages, potentially influencing manufacturing standards.
- The patent landscape includes overlapping global patents; thus, comprehensive freedom-to-operate analyses are essential.
- The expiration of the patent, circa 2035, presents significant commercial opportunities for generic manufacturers and innovators to develop alternative processes.
FAQs
1. Can the patent CN103491946 be directly used for commercial manufacturing?
Yes, if the process as claimed is adopted without modifications that infringe on the specific steps and conditions, it can be used for commercial manufacturing. However, competitors might develop alternative methods to avoid infringement.
2. How broad is the patent’s protection scope?
The patent's scope is limited to the particular process steps, reagents, and conditions detailed in the claims. It does not cover the compound itself or its pharmacological uses.
3. What are the risks of patent invalidation?
If prior art exists that predates the filing date and discloses similar synthesis methods, the patent could be challenged and potentially invalidated.
4. How does this patent impact generic drug development in China?
Once the patent expires, generic manufacturers can potentially produce similar compounds using their own synthesis methods, provided they do not infringe on the process claims during the patent term.
5. Are there any global patents similar to CN103491946?
Yes, similar patents exist worldwide that cover various synthesis routes for related compounds. Companies should conduct comprehensive patent searches to assess global patent risks and opportunities.
References:
- Chinese Patent Office. CN103491946. Method for preparation of a novel compound. 2013.
- Global Patent Database. Patent documents related to chemical synthesis processes for pharmaceuticals.
- Industry reports on green chemistry advancements in pharmaceutical manufacturing.
[Note: For precise legal advice and detailed patent landscape analysis, consult a registered patent attorney or professional IP strategist.]
